Treatment of vaginal candidosis with a single 500-mg clotrimazole pessary.

AUTOR(ES)

Milsom, I

RESUMO

In a double-blind study the therapeutic efficacy of a single 500-mg clotrimazole pessary was compared with that of a 200-mg clotrimazole pessary inserted once daily for three days in 72 patients with vaginal candidosis confirmed by culture. On clinical assessment four weeks after completion of treatment with the single-dose pessary the cure rate was 86% compared with 92% after the three-day regimen. There was no significant difference in the eradication rate between the single-dose (94%) and three-day regimens (89%). Four weeks after completion of treatment the recurrence rates by culture were 18% with the single-dose and 24% with the three-day regimen. The former treatment was well tolerated and as effective as the three-day clotrimazole regimen.

Documentos Relacionados

• Comparison of vaginal flora after treatment with a clotrimazole 500 mg vaginal pessary or a fluconazole 150 mg capsule for vaginal candidosis.
• Clotrimazole pessary compared with cream in treating women with vaginal candidosis.
• Econazole nitrate (150 mg) single dose vaginal pessary compared with clotrimazole (10%) single dose vaginal cream to treat women with vaginal candidiasis.
• Single dose treatment of vaginal candidosis: comparison of clotrimazole and isoconazole.
• Clotrimazole and econazole in the treatment of vaginal candidosis. A single-blind comparison.